About Perfuse Therapeutics
Perfuse Therapeutics is a company based in San Francisco (United States) founded in 2018 by Sevgi Gurkan was acquired by Bayer in May 2026.. Perfuse Therapeutics offers products and services including Endothelin Antagonist. Perfuse Therapeutics operates in a competitive market with competitors including Bausch & Lomb, Dopavision, Appasamy Associates, Katalyst Surgical and Lamellar, among others.
- Headquarter San Francisco, United States
- Founders Sevgi Gurkan
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Perfuse Therapeutics, Inc
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Perfuse Therapeutics
Perfuse Therapeutics offers a comprehensive portfolio of products and services, including Endothelin Antagonist. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Improves blood flow to retina to treat glaucoma and diabetic retinopathy.
Unlock access to complete
Product Management Team
4 people
Principal Team
2 people
Analytical Team
1 people
Leadership Team
1 people
Unlock access to complete
Funding Insights of Perfuse Therapeutics
- Total Funding Total Funding
- Total Rounds 1
- Last Round Last Round
- First Round First Round
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2020 | Amount | Series A - Perfuse Therapeutics | Valuation | Access Industries |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Perfuse Therapeutics
Perfuse Therapeutics has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Bayer and Access Industries. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment and holding company controlled by Len Blavatnik
|
Founded Year | Domain | Location | |
|
Life science solutions for healthcare and agriculture are delivered.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Perfuse Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Perfuse Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Perfuse Therapeutics Comparisons
Competitors of Perfuse Therapeutics
Perfuse Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Bausch & Lomb, Dopavision, Appasamy Associates, Katalyst Surgical and Lamellar, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Ophthalmic pharmaceuticals and instruments are developed for eye care.
|
|
| domain | founded_year | HQ Location |
Digital therapeutics for myopia are developed via retinal light stimulation.
|
|
| domain | founded_year | HQ Location |
Ophthalmic instruments and pharmaceutical products are developed for eye care.
|
|
| domain | founded_year | HQ Location |
Titanium ophthalmic surgical instruments are manufactured and repaired.
|
|
| domain | founded_year | HQ Location |
Develops patented medical devices and pharmaceuticals based on mimetics of extra-alveolar lamellar bodies
|
|
| domain | founded_year | HQ Location |
Precision instruments for eye surgery are designed and manufactured.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Perfuse Therapeutics
When was Perfuse Therapeutics founded?
Perfuse Therapeutics was founded in 2018 and raised its 1st funding round 2 years after it was founded.
Where is Perfuse Therapeutics located?
Perfuse Therapeutics is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Who is the current CEO of Perfuse Therapeutics?
Sevgi Gurkan is the current CEO of Perfuse Therapeutics. They have also founded this company.
What does Perfuse Therapeutics do?
Perfuse Therapeutics was founded in 2018 in San Francisco, United States, within the biotechnology sector. Focus is placed on developing treatments for eye disorders, including glaucoma and retinal diseases. A proprietary technology is employed to enhance retinal perfusion, targeting improved outcomes in these conditions. Operations center on therapeutic innovation for ocular health applications.
Who are the top competitors of Perfuse Therapeutics?
Perfuse Therapeutics's top competitors include Bausch & Lomb, Appasamy Associates and Katalyst Surgical.
What products or services does Perfuse Therapeutics offer?
Perfuse Therapeutics offers Endothelin Antagonist.
Who are Perfuse Therapeutics's investors?
Perfuse Therapeutics has 2 investors. Key investors include Bayer, and Access Industries.